Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

527
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...
527
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
Allergic Drug Reactions01:27

Allergic Drug Reactions

1.3K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.3K
Allergic Reactions02:06

Allergic Reactions

31.9K
Overview
31.9K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

895
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
895
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

2.3K
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.3K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Restoring balance in atopic disorders: insights into type 2 immunity and chronic inflammation.

Frontiers in immunology·2026
Same author

Neuronal responses to cytokines limit intestinal hypermotility and systemic effects of colonic inflammation.

iScience·2026
Same author

Emerging Therapies for Anaphylaxis.

Immunology and allergy clinics of North America·2026
Same author

Correction: Dupilumab Reduces Pruritus in Clinically Distinct Dermatologic Diseases: Data from Clinical Trials on Atopic Dermatitis, Prurigo Nodularis, and Chronic Spontaneous Urticaria.

Dermatology and therapy·2026
Same author

Dupilumab subgroup responder analysis: a <i>post hoc</i> analysis from LIBERTY PRIME and PRIME2 in prurigo nodularis.

The Journal of dermatological treatment·2026
Same author

Dupilumab Improves Daily Symptom Burden in Adult Patients with Prurigo Nodularis: Post Hoc Analysis from LIBERTY PN-PRIME and PRIME2 Studies.

Dermatology and therapy·2026
Same journal

Impact of cognitive impairment and depression on asthma in older patients.

The journal of allergy and clinical immunology. In practice·2026
Same journal

Refractory Atopic Dermatitis Unmasking Mycosis Fungoides During Targeted Therapy.

The journal of allergy and clinical immunology. In practice·2026
Same journal

ASTHMA CONTROL BEFORE AND AFTER CHANGING GAS STOVES TO ELECTRIC STOVES.

The journal of allergy and clinical immunology. In practice·2026
Same journal

Multiplex Cytokine LTT Reveals Strong T Cell Responses to Multiple Drugs in NIDHR-Associated Multiple Drug Hypersensitivity.

The journal of allergy and clinical immunology. In practice·2026
Same journal

Allergic Fungal Rhinosinusitis: Distinct Clinical Features, Diagnostic Challenges, and Evolving Therapeutic Strategies.

The journal of allergy and clinical immunology. In practice·2026
Same journal

Effectiveness of treatment with tezepelumab in patients with severe asthma, smoking asthmatics and patients with severe Asthma and COPD: A real-world cohort study.

The journal of allergy and clinical immunology. In practice·2026
查看所有相关文章

相关实验视频

Updated: Jan 10, 2026

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays
13:22

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays

Published on: October 23, 2019

8.2K

关于激酶抑制剂在过敏中的最新情况

Melanie C Dispenza1, Brian S Kim2

  • 1Division of Allergy and Clinical Immunology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

The journal of allergy and clinical immunology. In practice
|November 24, 2025
PubMed
概括
此摘要是机器生成的。

激酶抑制剂,如布鲁顿的激酶抑制剂.

关键词:
过敏反应 (ANAPHYLAXIS) 是一种过敏反应.布鲁顿的铁氨基激酶.亚努斯酶是亚努斯酶的一种.这是一款KIT KIT.亚托邦性皮肤炎的发生.慢性 ?? 疹是一种慢性疹.食物过敏 食物过敏激酶激酶的作用是什么

更多相关视频

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

9.5K
A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors
12:40

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

Published on: December 7, 2014

15.2K

相关实验视频

Last Updated: Jan 10, 2026

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays
13:22

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays

Published on: October 23, 2019

8.2K
Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

9.5K
A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors
12:40

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

Published on: December 7, 2014

15.2K

科学领域:

  • 免疫学和药理学
  • 药物发现和开发 药物发现和开发

背景情况:

  • 激酶抑制剂正在彻底改变过敏治疗,超越了癌症治疗.
  • 选择性抑制剂设计的进步提高了免疫介导疾病的安全性和有效性.

研究的目的:

  • 审查最近对过敏疾病的激酶抑制剂开发的进展.
  • 总结关键抑制剂的机制论证,临床试验发现和安全性概况.

主要方法:

  • 对布鲁顿氨酸激酶 (BTK),雅努斯激酶 (JAK) 和KIT抑制剂的当前文献的综述.
  • 对已批准和新兴疗法的临床试验数据和安全概况的分析.
  • 讨论将这些抑制剂纳入临床实践的实际考虑.

主要成果:

  • BTK 抑制剂提供IgE介导反应的快速控制,已被批准用于慢性疹.
  • 雅克抑制剂在阿托皮性皮肤炎中显示出显著的抗炎和抗作用.
  • 基特抑制剂通过巨细胞抑制为巨细胞症和慢性疹症提供了新的治疗途径.

结论:

  • 激酶抑制剂在管理过敏和免疫介导疾病方面代表了显著的治疗进步.
  • 向抑制BTK,JAK和KIT通路提供了有效的治疗选择,可管理的安全性.